173 related articles for article (PubMed ID: 14558033)
21. Recurrences of free trisomy 21: analysis of data from the National Down Syndrome Cytogenetic Register.
Morris JK; Mutton DE; Alberman E
Prenat Diagn; 2005 Dec; 25(12):1120-8. PubMed ID: 16231400
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the incidence and likelihood ratios for chromosomal abnormalities in fetuses with common central nervous system malformations.
Goetzinger KR; Stamilio DM; Dicke JM; Macones GA; Odibo AO
Am J Obstet Gynecol; 2008 Sep; 199(3):285.e1-6. PubMed ID: 18771985
[TBL] [Abstract][Full Text] [Related]
23. Prenatal diagnosis of trisomy 12 mosaicism: normal development of a 3 years old female child.
Staals JE; Schrander-Stumpel CT; Hamers G; Fryns JP
Genet Couns; 2003; 14(2):233-7. PubMed ID: 12872819
[TBL] [Abstract][Full Text] [Related]
24. Prenatal diagnosis of trisomy 18p and distal 21q22.3 deletion.
Chen CP; Chern SR; Lee CC; Chen LF; Chin DT; Tzen CY; Wang W
Prenat Diagn; 2003 Sep; 23(9):758-61. PubMed ID: 12975789
[TBL] [Abstract][Full Text] [Related]
25. First-trimester combined screening for Down syndrome and other fetal anomalies.
O'Leary P; Breheny N; Dickinson JE; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125
[TBL] [Abstract][Full Text] [Related]
26. [Trisomy 21 and its prenatal detection in the Canton of Vaud (1980-1996)].
Pescia G; Addor MC
Schweiz Med Wochenschr; 2000 Sep; 130(38):1332-8. PubMed ID: 11064925
[TBL] [Abstract][Full Text] [Related]
27. Effect of fetal diagnosis on the outcomes of second-trimester pregnancy termination for fetal abnormalities: a pilot study.
Lo TK; Lau WL; Lai FK; Lam HS; Tse HY; Leung WC; Chin RK
J Matern Fetal Neonatal Med; 2008 Aug; 21(8):523-7. PubMed ID: 18609362
[TBL] [Abstract][Full Text] [Related]
28. Trisomy 13 mosaicism: study of serial cytogenetic changes in a case from early pregnancy to infancy.
Chen M; Yeh GP; Shih JC; Wang BT
Prenat Diagn; 2004 Feb; 24(2):137-43. PubMed ID: 14974123
[TBL] [Abstract][Full Text] [Related]
29. Detection of mosaicism for primary trisomies in prenatal samples by QF-PCR and karyotype analysis.
Donaghue C; Mann K; Docherty Z; Ogilvie CM
Prenat Diagn; 2005 Jan; 25(1):65-72. PubMed ID: 15662691
[TBL] [Abstract][Full Text] [Related]
30. Current French practices for prenatal diagnosis of trisomy 21: a population-based study in Paris, 1992-97.
De Vigan C; Vodovar V; Vérité V; Dehé S; Goujard J
Prenat Diagn; 1999 Dec; 19(12):1113-8. PubMed ID: 10590427
[TBL] [Abstract][Full Text] [Related]
31. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program.
Krantz DA; Hallahan TW; Macri VJ; Macri JN
Prenat Diagn; 2005 Aug; 25(8):635-40. PubMed ID: 16049986
[TBL] [Abstract][Full Text] [Related]
32. Prenatal diagnosis of mosaic trisomy 16 associated with congenital diaphragmatic hernia and elevated maternal serum alpha-fetoprotein and human chorionic gonadotrophin.
Chen CP; Shih JC; Chern SR; Lee CC; Wang W
Prenat Diagn; 2004 Jan; 24(1):63-6. PubMed ID: 14755412
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of trisomy 18 screening using the second-trimester triple test.
Meier C; Huang T; Wyatt PR; Summers AM
Prenat Diagn; 2003 Jun; 23(6):443-6. PubMed ID: 12813756
[TBL] [Abstract][Full Text] [Related]
34. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K; Crossley JA; Aitken DA; Nicolaides KH
Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
[TBL] [Abstract][Full Text] [Related]
35. Dichorionic triamniotic triplet pregnancy with monozygotic twins discordant for trisomy 13 after preimplantation genetic screening: case report.
Taylor DM; Thum MY; Abdalla H
Fertil Steril; 2008 Nov; 90(5):2017.e5-9. PubMed ID: 18402943
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
Colvin J; Bower C; Dickinson JE; Sokol J
Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
[TBL] [Abstract][Full Text] [Related]
37. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
38. The timing of demise in fetuses with trisomy 21 and trisomy 18.
Won RH; Currier RJ; Lorey F; Towner DR
Prenat Diagn; 2005 Jul; 25(7):608-11. PubMed ID: 16032775
[TBL] [Abstract][Full Text] [Related]
39. The level of ADAM12-S in maternal serum is an early first-trimester marker of fetal trisomy 18.
Laigaard J; Christiansen M; Fröhlich C; Pedersen BN; Ottesen B; Wewer UM
Prenat Diagn; 2005 Jan; 25(1):45-6. PubMed ID: 15662668
[TBL] [Abstract][Full Text] [Related]
40. Increased fetal nuchal translucency as a sole clue in the prenatal diagnosis of a fetus with trisomy 13.
Ki KD; Kim SR; Lee WI
Fetal Diagn Ther; 2009; 26(1):54-6. PubMed ID: 19816033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
